Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Peer power: could community education boost cancer screening?

NCT ID NCT07748377

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This pilot trial tests a community-based program designed to help Chinese immigrants aged 45-75 get up-to-date on colorectal and breast cancer screening. The program includes a group education session led by a community health worker and personalized help navigating the healthcare system. The goal is to see if this approach is acceptable, feasible, and effective in increasing screening rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A community-based program combining group education sessions led by a community health worker and peer navigation assistance to encourage cancer screening.
What this could lead to
If successful, this approach could increase cancer screening rates in underserved communities, potentially leading to earlier detection and better outcomes.
What could go wrong
This is a small pilot study, so results may not apply broadly. The program's success depends on participant engagement and may not be sustainable without ongoing support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 45-75 years old * Self-identify as Chinese and born outside of the U.S. * Speaks Mandarin, Cantonese, or English * Not up to date on BC screening (i.e., have not had a mammogram within the past two years) * Not up to date on CRC screening (i.e., have not had any of the following tests) * Colonoscopy within the past 10 years * Fecal immunochemical tests/fecal occult blood tests within the past year or multi-target stool DNA test within the past three years * Flexible sigmoidoscopy within the past 5 years * CT colonography within the past 5 years Exclusion Criteria: * Life expectancy ≤ 10 years or other pre-existing conditions whereby CRC or BC screening would not be recommended * Personal history of BC or CRC * Prior history of a total colectomy or mastectomy * Lacks capacity to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Charles B. Wang Community Health Center

    New York, New York, 10013, United States

  • Henry Street Settlement

    New York, New York, 10002, United States

  • St. Margaret's House

    New York, New York, 10038, United States

  • The Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • United Chinese Association of Brooklyn

    New York, New York, 11223, United States

  • University Settlement

    New York, New York, 10002, United States

  • VNS Health Chinatown Community Center

    New York, New York, 10013, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.